CNTX icon

Context Therapeutics
CNTX

Overview Fund Activity

22 hedge funds and large institutions have $3.58M invested in Context Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ABG
1
Ally Bridge Group
New York
$1.05M
2
AAA
2
Affinity Asset Advisors
New York
$428K
3
UOC
3
UBS O'Connor
Illinois
$105K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$172K
5
CHAM
5
Clear Harbor Asset Management
Connecticut
$57.6K

Top Sellers

1
Two Sigma Investments
1
Two Sigma Investments
New York
$42.9K
2
VF
2
Virtu Financial
New York
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$0
5
BBA
5
Baader Bank Aktiengesellschaft
Germany
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BBA
26
Baader Bank Aktiengesellschaft
Germany
– – -10,651 Closed
UBS Group
27
UBS Group
Switzerland
– – -5,767 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2